No Data
Neo Marketing - For the fiscal year ending September 2024, although there will be a decrease in revenue, focus will be on activities aimed at expanding the medium- to long-term order system and service provision system.
Neo Marketing Co., Ltd. <4196> announced its consolidated financial results for the fiscal year ending September 2024 on the 13th. Revenue decreased by 7.8% compared to the previous period to 2.098 billion yen, operating profit fell by 95.0% to 0.015 billion yen, ordinary profit decreased by 95.5% to 0.014 billion yen, and net income attributable to shareholders of the parent company dropped by 25.7% to 0.147 billion yen. During the period, emphasis was placed on recruitment and training activities in line with the medium-term management plan. As part of the initiatives to strengthen organizational and sales capabilities, there are marketing consultant positions.
Neo Marketing: Financial results presentation materials for the fiscal year ending 2024/9
Neo Marketing: Summary of Financial Results for the Fiscal Year Ending 2024/9 [Japanese GAAP] (Consolidated)
Part 2 of the previous day's moving stocks include M&A SOKO Holdings, Sakura Internet, Big Camera, etc.
Stock name (code) 20-day closing price ⇒ Previous day comparison Kitagawa Seiki <6327> 723-48. June 2015 operating profit is expected to decrease by 38%. MonotaRO <3064> 2,458.5-7. Sell off profits against the recent rise continues. Neo Marketing <4196> 1107 +20 Release a beta version of the new interview service "Chat AI Research DEMO!" that takes advantage of the latest AI technology. M&A Consulting Holdings <9552> 2785
Stocks that moved the previous day, part 1: 7&iHD, Shionogi & Co., Ltd., Double A, etc.
Stock name <code>19 closing price ⇒ comparison with the previous dayAsuka Pharmaceutical HD <4886> 2,309 + 21 Obtained approval for manufacturing and selling oral contraceptive drospirenone in South Korea. In the afternoon, the increase narrowed. 7&iHD <3382> 2,161 + 400 Acquired proposal reported from Canada's largest convenience store chain, Alimentation Couche-Tard. Renascience <4889> 353 + 14 Clinical performance tests of AI to predict insulin dosage for diabetes patients have started. Economic <3802>
Active and newly listed stocks during the morning session.
INPEX <1605> 2204 -37.5. The price of crude oil fell due to expectations of easing tensions in the Middle East. Pan Pacific HD <7532> 3519 -203. Predicted to have only 7% operating profit this year compared to a 33% increase in the previous period. Sumitomo Pharma <4506> 588 +34. Domestic securities raised the target stock price. Joukan Electric Industry <7711> 1560 +63. Revision of the national strategy for fusion power generation is the key. Asmark <4197> 2366 +400. Established a shareholder benefits system as part of the new global strategy.
No Data
No Data